S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Merida Merger Corp. I (MCMJ) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

MCMJ vs. GLEO, GSDI, CCLD, LEXX, NMTC, PLUR, PRE, CASI, FEMY, and MRM

Should you be buying Merida Merger Corp. I stock or one of its competitors? The main competitors of Merida Merger Corp. I include Galileo Acquisition (GLEO), Global System Dynamics (GSDI), CareCloud (CCLD), Lexaria Bioscience (LEXX), NeuroOne Medical Technologies (NMTC), Pluri (PLUR), Prenetics Global (PRE), CASI Pharmaceuticals (CASI), Femasys (FEMY), and MEDIROM Healthcare Technologies (MRM).

Merida Merger Corp. I vs.

Galileo Acquisition (NYSE:GLEO) and Merida Merger Corp. I (NASDAQ:MCMJ) are both small-cap industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, community ranking, analyst recommendations and earnings.

In the previous week, Merida Merger Corp. I's average media sentiment score of 0.00 equaled Galileo Acquisition'saverage media sentiment score.

Company Overall Sentiment
Galileo Acquisition Neutral
Merida Merger Corp. I Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Galileo AcquisitionN/AN/A-$1.53MN/AN/A
Merida Merger Corp. IN/AN/A-$1.87MN/AN/A

Galileo Acquisition's return on equity of -122.92% beat Merida Merger Corp. I's return on equity.

Company Net Margins Return on Equity Return on Assets
Galileo AcquisitionN/A -3,653.35% -9.17%
Merida Merger Corp. I N/A -122.92%-4.64%

58.2% of Galileo Acquisition shares are owned by institutional investors. Comparatively, 76.2% of Merida Merger Corp. I shares are owned by institutional investors. 21.7% of Merida Merger Corp. I shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Galileo Acquisition has a beta of 0.15, indicating that its stock price is 85% less volatile than the S&P 500. Comparatively, Merida Merger Corp. I has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Galileo Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Merida Merger Corp. I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Galileo Acquisition and Merida Merger Corp. I both received 1 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Galileo AcquisitionOutperform Votes
1
100.00%
Underperform Votes
No Votes
Merida Merger Corp. IOutperform Votes
1
100.00%
Underperform Votes
No Votes

Summary

Merida Merger Corp. I beats Galileo Acquisition on 5 of the 6 factors compared between the two stocks.

Get Merida Merger Corp. I News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCMJ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCMJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCMJ vs. The Competition

MetricMerida Merger Corp. IPrepackaged Software IndustryMedical SectorNASDAQ Exchange
Market Cap$31.16M$22.10B$4.77B$7.46B
Dividend YieldN/A2.17%2.97%3.99%
P/E RatioN/A89.35195.6315.61
Price / SalesN/A8.532,347.4389.31
Price / CashN/A62.9847.2835.31
Price / Book-9.049.494.624.19
Net Income-$1.87M$382.08M$102.17M$212.33M

Merida Merger Corp. I Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GLEO
Galileo Acquisition
0 of 5 stars
$1.67
-0.6%
N/A+481.0%$29.06MN/A0.002
GSDI
Global System Dynamics
0 of 5 stars
$10.69
flat
N/AN/A$35.38MN/A0.00N/A
CCLD
CareCloud
3.1215 of 5 stars
$1.16
flat
$3.17
+173.0%
-68.0%$18.70M$117.06M-0.293,600News Coverage
Positive News
Gap Down
LEXX
Lexaria Bioscience
2.4325 of 5 stars
$2.31
+16.1%
$12.00
+419.5%
+7.8%$29.78M$230,000.00-3.405News Coverage
NMTC
NeuroOne Medical Technologies
1.1341 of 5 stars
$1.15
+2.7%
$2.20
+91.3%
-29.3%$29.82M$1.95M-1.6916Gap Down
PLUR
Pluri
0 of 5 stars
$5.76
+1.6%
N/A-29.3%$29.84M$290,000.00-1.24123Gap Down
PRE
Prenetics Global
1.0704 of 5 stars
$3.21
-8.0%
$9.00
+180.4%
-74.4%$29.34M$21.74M-0.67400
CASI
CASI Pharmaceuticals
3.6749 of 5 stars
$2.25
-10.0%
$12.00
+433.3%
-32.1%$30.15M$33.88M-1.11176Gap Down
FEMY
Femasys
2.0223 of 5 stars
$1.31
-2.2%
$11.33
+765.1%
+20.4%$28.95M$1.07M-1.4234Gap Down
MRM
MEDIROM Healthcare Technologies
0 of 5 stars
$5.93
-1.0%
N/A-1.3%$28.94M$53.25M0.00434

Related Companies and Tools

This page (NASDAQ:MCMJ) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners